[1st therapeutic results with the use of Trenimon in chronic hemoblastosis].
D000970:Antineoplastic Agents / Q000628:therapy*; D001853:Bone Marrow; D019046:Bone Marrow Neoplasms; D040181:Genetic Diseases, X-Linked; D006413:Hematopoietic System; D006801:Humans; D007938:Leukemia / Q000628:therapy*; D007943:Leukemia, Hairy Cell / Q000628:therapy*; D008206:Lymphatic Diseases / Q000628:therapy*; D009369:Neoplasms; D016511:Severe Combined Immunodeficiency; D014228:Triaziquone
D000970:Antineoplastic Agents; D014228:Triaziquone
ANTINEOPLASTIC AGENTS/therapy; BONE MARROW/neoplasms; HEMATOPOIETIC SYSTEM/neoplasms; LEUKEMIA/therapy; RETICULOENDOTHELIOSIS/therapy